Literature DB >> 26246832

The etiology and prevention of breast cancer.

Ercole L Cavalieri1, Eleanor G Rogan1.   

Abstract

Metabolism of estrogens via the catechol estrogen pathway is characterized by a balanced set of activating and protective enzymes (homeostasis). Disruption of homeostasis, with excessive production of catechol estrogen quinones, can lead to reaction of these quinones with DNA to form depurinating estrogen-DNA adducts. Some of the mutations generated by these events can lead to initiation of breast cancer. A wealth of evidence, from studies of metabolism, mutagenicity, cell transformation and carcinogenicity, demonstrates that estrogens are genotoxic. Women at high risk for breast cancer, or diagnosed with the disease, have relatively high levels of depurinating estrogen-DNA adducts compared to normal-risk women. The dietary supplements N-acetylcysteine and resveratrol can inhibit formation of catechol estrogen quinones and their reaction with DNA to form estrogen-DNA adducts, thereby preventing initiation of breast cancer.

Entities:  

Year:  2012        PMID: 26246832      PMCID: PMC4522944          DOI: 10.1016/j.ddmec.2013.02.001

Source DB:  PubMed          Journal:  Drug Discov Today Dis Mech        ISSN: 1740-6765


  109 in total

1.  The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.

Authors:  Muhammad Zahid; Ekta Kohli; Muhammad Saeed; Eleanor Rogan; Ercole Cavalieri
Journal:  Chem Res Toxicol       Date:  2006-01       Impact factor: 3.739

Review 2.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

Authors:  P T Männistö; S Kaakkola
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

3.  Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors.

Authors:  E L Cavalieri; S Kumar; R Todorovic; S Higginbotham; A F Badawi; E G Rogan
Journal:  Chem Res Toxicol       Date:  2001-08       Impact factor: 3.739

Review 4.  Estrogens as endogenous genotoxic agents--DNA adducts and mutations.

Authors:  E Cavalieri; K Frenkel; J G Liehr; E Rogan; D Roy
Journal:  J Natl Cancer Inst Monogr       Date:  2000

5.  Mutagenicity assays of estrogenic hormones in mammalian cells.

Authors:  C Drevon; C Piccoli; R Montesano
Journal:  Mutat Res       Date:  1981-05       Impact factor: 2.433

6.  Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione.

Authors:  K Cao; D E Stack; R Ramanathan; M L Gross; E G Rogan; E L Cavalieri
Journal:  Chem Res Toxicol       Date:  1998-08       Impact factor: 3.739

7.  p-Quinone methides are the major decomposition products of catechol estrogen o-quinones.

Authors:  J L Bolton; L Shen
Journal:  Carcinogenesis       Date:  1996-05       Impact factor: 4.944

8.  Role of hormones in mammary neoplasia.

Authors:  S Nandi
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

9.  Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.

Authors:  J R Pasqualini; G Chetrite; C Blacker; M C Feinstein; L Delalonde; M Talbi; C Maloche
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

Review 10.  Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.

Authors:  Richard Santen; Ercole Cavalieri; Eleanor Rogan; Jose Russo; Joseph Guttenplan; James Ingle; Wei Yue
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

View more
  7 in total

1.  Preface.

Authors:  Ercole Cavalieri; Eleanor G Rogan
Journal:  Drug Discov Today Dis Mech       Date:  2012-12-22

2.  Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjects.

Authors:  Yafei Zhang; Xianling Zeng; Hongwei Lu; Hong Ji; Enfa Zhao; Yiming Li
Journal:  Oncotarget       Date:  2016-10-18

3.  Association of interleukin 10 rs1800896 polymorphism with susceptibility to breast cancer: a meta-analysis.

Authors:  ZiYin Zhu; Ji-Bin Liu; Xi Liu; LinXue Qian
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

Review 4.  The role of Th17 cells in the pathogenesis and treatment of breast cancer.

Authors:  Vahid Karpisheh; Majid Ahmadi; Kazem Abbaszadeh-Goudarzi; Mehran Mohammadpour Saray; Asal Barshidi; Hamed Mohammadi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Cancer Cell Int       Date:  2022-03-05       Impact factor: 5.722

Review 5.  The Role of Extracellular Matrix Proteins in Breast Cancer.

Authors:  Arkadiusz Lepucki; Kinga Orlińska; Aleksandra Mielczarek-Palacz; Jacek Kabut; Pawel Olczyk; Katarzyna Komosińska-Vassev
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

Review 6.  Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  Clin Transl Med       Date:  2016-03-15

7.  ERCC1 rs11615 polymorphism increases susceptibility to breast cancer: a meta-analysis of 4547 individuals.

Authors:  Bingjie Li; Xiaoqing Shi; Yingying Yuan; Mengle Peng; Huifang Jin; Dongchun Qin
Journal:  Biosci Rep       Date:  2018-06-21       Impact factor: 3.976

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.